July 01, 2025 — NANO-X Imaging Ltd. recently announced a clinical and educational collaboration with Keiser University, one of Florida’s largest private, non-profit university.

July 2, 2025 — Philips has received FDA 510(k) clearance for SmartSpeed Precise[1] MR’s latest deep learning reconstruction software, marking a major milestone in the journey toward autonomous, personalized MRI. SmartSpeed Precise is the industry's first integrated dual AI solution, delivering up to 3x faster scanning[2] and up to 80% sharper images[3] —  in one click. 

Multimodal AI Shows No Evidence of Bias in Prostate Cancer Study

A new study published in JCO Clinical Cancer Informatics tackles a critical challenge in cancer diagnostics: ensuring that artificial intelligence (AI) performs equitably across racially diverse patient populations. This research marks a milestone in prostate cancer care, presenting the first large-scale comparative analysis of a digital pathology AI prognostic model in both African American and non–African American patients. The findings offer key insights into the performance of AI in addressing bias in oncologic outcomes.

July 1, 2025 — UPDATE: The final paper is now available at:

JMIR AI - ChatGPT-4–Driven Liver Ultrasound Radiomics Analysis: Diagnostic Value and Drawbacks in a Comparative Study

 

ORIGINALLY POSTED June 3, 2025 — In a collaborative study between the Departments of Radiology at the Children’s Hospital of Philadelphia (CHOP) and the University of Pennsylvania, researchers evaluated the potential of using ChatGPT-4 for diagnosing liver disease using ultrasound images.

June 26, 2025 — FUJIFILM VisualSonics Inc., a provider of ultra-high frequency ultrasound and photoacoustic imaging systems, has announced the availability of the multi-modal Vevo F2 LAZR-X20 Photoacoustic Imaging Platform. The system features high-powered, intelligent laser technology for advanced tissue characterization with high anatomical accuracy for preclinical animal models.

Merge by Merative empowers healthcare organizations with advanced medical imaging solutions to enhance workflows, optimize care delivery, and improve patient outcomes. Trusted by 6 of the 10 largest U.S. health systems and built on a cloud-native foundation, Merge’s portfolio includes solutions for Vendor-Neutral Archive (VNA), PACS, Workflow Orchestration, Cardiology and hemodynamics, and digital pathology. Learn more at merative.com/merge-imaging.

June 18, 2025  — Probo Medical, a provider of medical imaging equipment, service, and support, has announced a strategic partnership with MedServ Marketplace Inc., a two-sided healthcare service platform that connects Biomedical Equipment Technicians (BMETs) and Field Service Engineers (FSEs) with healthcare providers (HCPs), Original Equipment Manufacturers (OEMs) and Independent Service Organizations (ISO) in need of maintenance, repair, and operational support.

June 26, 2025 — Siemens Healthineers has received Food and Drug Administration clearance for the Magnetom Flow.Ace, its first 1.5 tesla (T) platform for magnetic resonance (MR) imaging with a closed helium circuit and no quench pipe, significantly reducing reliance on helium. The system, which has a 60 cm bore, is also the first Siemens Healthineers MR scanner to be marketed to the veterinary radiology community as well as for general radiology

June 26, 2025 – Quibim, a global provider of quantitative medical imaging solutions, has launched AI-QUAL, a new feature to Quibim’s QP-Prostate platform, that automates the assessment of prostate MRI image quality in accordance with the PI-QUAL v2 guidelines. This marks a significant step forward in standardizing prostate MRI quality, enhancing diagnostic confidence, and streamlining radiology workflows.

June 25, 2025 — Royal Philips and Indiana-based Methodist Hospitals recently announced the healthcare provider’s strategic investment in Philips’ advanced portfolio of image-guided therapy (IGT) solutions that integrate imaging systems and software, with specialized diagnostic and therapeutic devices. The new interventional suites will support critical health needs within the community including including active stroke treatment, oncology therapies, complex cardiovascular intervention and care for other prevalent health conditions.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now